Merit Medical Systems, Inc. (MMSI)
86.63
-0.06
(-0.07%)
USD |
NASDAQ |
Nov 13, 16:00
86.62
-0.01
(-0.01%)
After-Hours: 19:59
Merit Medical Systems Net Income (Quarterly) : 42.31M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 42.31M |
| June 30, 2026 | 38.80M |
| March 31, 2026 | 41.00M |
| December 31, 2025 | 38.01M |
| September 30, 2025 | 27.76M |
| June 30, 2025 | 32.58M |
| March 31, 2025 | 30.15M |
| December 31, 2024 | 27.95M |
| September 30, 2024 | 28.44M |
| June 30, 2024 | 35.73M |
| March 31, 2024 | 28.24M |
| December 31, 2023 | 27.63M |
| September 30, 2023 | 25.83M |
| June 30, 2023 | 20.24M |
| March 31, 2023 | 20.70M |
| December 31, 2022 | 33.40M |
| September 30, 2022 | 15.27M |
| June 30, 2022 | 15.30M |
| March 31, 2022 | 10.54M |
| December 31, 2021 | 20.61M |
| September 30, 2021 | 11.97M |
| June 30, 2021 | 4.916M |
| March 31, 2021 | 10.96M |
| December 31, 2020 | 15.38M |
| September 30, 2020 | -3.009M |
| Date | Value |
|---|---|
| June 30, 2020 | -19.06M |
| March 31, 2020 | -3.154M |
| December 31, 2019 | -4.205M |
| September 30, 2019 | -3.398M |
| June 30, 2019 | 6.859M |
| March 31, 2019 | 6.195M |
| December 31, 2018 | 9.188M |
| September 30, 2018 | 16.62M |
| June 30, 2018 | 10.94M |
| March 31, 2018 | 5.269M |
| December 31, 2017 | 6.806M |
| September 30, 2017 | -3.569M |
| June 30, 2017 | 9.483M |
| March 31, 2017 | 14.80M |
| December 31, 2016 | 7.506M |
| September 30, 2016 | 0.973M |
| June 30, 2016 | 7.29M |
| March 31, 2016 | 4.351M |
| December 31, 2015 | 6.409M |
| September 30, 2015 | 4.818M |
| June 30, 2015 | 7.401M |
| March 31, 2015 | 5.174M |
| December 31, 2014 | 8.671M |
| September 30, 2014 | 7.764M |
| June 30, 2014 | 3.716M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Globus Medical, Inc. | 141.17M |
| Glaukos Corp. | 2.018M |
| Becton, Dickinson & Co. | 696.00M |
| DexCom, Inc. | 275.10M |
| Haemonetics Corp. | 46.30M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 416.89M |
| Total Expenses (Quarterly) | 374.58M |
| EPS Diluted (Quarterly) | 0.7008 |
| Enterprise Value | 5.505B |
| Gross Profit Margin (Quarterly) | 48.53% |
| Profit Margin (Quarterly) | 10.15% |
| Earnings Yield | 3.07% |
| Operating Earnings Yield | 4.20% |
| Normalized Earnings Yield | 3.157 |